Modern Rheumatology
Volume 29, 2019 - Issue 2
Open access
2,469
Views
13
CrossRef citations to date
0
Altmetric
Special Review: IL-6 inhibitor
A benefit and the prospects of IL-6 inhibitors in idiopathic multicentric Castleman's disease
Tomohiro KogaUnit of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; ;Center for Bioinformatics and Molecular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; Correspondence[email protected]
, Remi SumiyoshiUnit of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;
, Atsushi KawakamiUnit of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;
& Kazuyuki YoshizakiDepartment of Biomolecular Science and Regulation, The Institute of Scientific and Industrial Research, Osaka University, Osaka, Japan
Pages 302-305
|
Received 12 Sep 2018, Accepted 26 Sep 2018, Published online: 14 Jan 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.